Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia
Year: 2009
Type: article
Study design: Observational Study
Abstract: Converging evidence suggests too few activation-ready N-methyl-D-aspartic acid (NMDA) receptor complexes in the postsynaptic density in schizophrenia. Postsynaptic density protein 95 (PSD95), Synaptic GTPase-activating protein (SynGAP), and Multiple PDZ domain protein (MUPP1) are integral components of the NMDA receptor signaling complex, and help facilitate signaling, trafficking, and stabilization. We hypothesized that deficits involving these molecules may contribute to the pathophysiology of schizophrenia. To test our hypothesis, we measured protein expression of PSD95, SynGAP, and MUPP1 in the anterior cingulate cortex and dorsolateral prefrontal cortex. We found decreased PSD95 expression in the anterior cingulate cortex. Antipsychotic medication analyses showed decreased SynGAP expression in the anterior cingulate cortex in patients off medication when analyzed against our comparison group. These data suggest that NMDA receptor complex formation, localization, and downstream signaling may be abnormal in schizophrenia.
Source: Neuroreport
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Defects of subcellular glutamate transporter localization in schizophrenia, White Matter Abnormalities in Schizophrenia, Schizophrenia as a Disorder of Glutamate Receptor Trafficking, Contribution of cell cycle processes to myelin deficits in schizophrenia, Glutamate Transporter Expression in Schizophrenia
OpenAlex ID: W2029442966
